SEC Form 4 · accession 0001562180-19-000164
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeryl L Hilleman
Officer — Chief Financial Officer
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 8:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jan 1, 2019 | F | 3,548 | $26.5675 | D | 19,884 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares tendered in payment of the tax withholding obligation.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.43 to $26.86, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F3Includes 12,000 Restricted Stock Units.